Drug recall · September 18, 2019
Pramipexole Dihydrochloride Tablets 0.125 mg recall
Why: Subpotent Drug: Out of specification result during stability study in Pramipexole Dihydrochloride Tablets 0.125 mg
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Pramipexole Dihydrochloride Tablets 0.125 mg,90-count bottle, Rx Only, Manufactured for: Macleods Pharma USA, Inc. Plainsboro, NJ 08536, Manufactured by: Macleods Phamaceuticals Ltd. Baddi Himachal Pradesh, India. NDC 33342-031-10
- Lots / codes
Lot #BPA801A, EXP 12/2020
- Quantity
- 1837 90-count bottles
- Company
- Macleods Pharma Usa Inc, Plainsboro, NJ
- Distribution
- Distributed Nationwide in the USA
- Initiated
- August 21, 2019 · Voluntary: Firm initiated
- Classified
- September 11, 2019
- Reported
- September 18, 2019
- Ended
- January 28, 2021
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Pramipexole
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.